Page last updated: 2024-09-05

biotin and exenatide

biotin has been researched along with exenatide in 2 studies

Compound Research Comparison

Studies (biotin)	Trials (biotin)	Recent Studies (post-2010) (biotin)	Studies (exenatide)	Trials (exenatide)	Recent Studies (post-2010) (exenatide)
14,847	95	3,882	2,806	383	2,016

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
McCarty, MF	1
Chae, SY; Jin, CH; Kim, TH; Lee, KC; Lee, S; Son, S; Um, KA; Youn, YS	1

Other Studies

2 other study(ies) available for biotin and exenatide

Article	Year
Exenatide and biotin in conjunction with a protein-sparing fast for normalization of beta cell function in type 2 diabetics. Medical hypotheses, 2007, Volume: 69, Issue:4 Topics: Biotin; Cell Differentiation; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Protein-Restricted; Drug Therapy, Combination; Exenatide; Fasting; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Peptides; Venoms	2007
A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice. Journal of controlled release : official journal of the Controlled Release Society, 2009, Feb-10, Volume: 133, Issue:3 Topics: Administration, Oral; Animals; Area Under Curve; Biotin; Biotinylation; Blood Glucose; Body Fluids; Drug Carriers; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Obese; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Receptors, Leptin; Succinimides; Trypsin; Venoms	2009

Article

Year

Exenatide and biotin in conjunction with a protein-sparing fast for normalization of beta cell function in type 2 diabetics.

Medical hypotheses, 2007, Volume: 69, Issue:4

Topics: Biotin; Cell Differentiation; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Protein-Restricted; Drug Therapy, Combination; Exenatide; Fasting; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Peptides; Venoms

2007

A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.

Journal of controlled release : official journal of the Controlled Release Society, 2009, Feb-10, Volume: 133, Issue:3

Topics: Administration, Oral; Animals; Area Under Curve; Biotin; Biotinylation; Blood Glucose; Body Fluids; Drug Carriers; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Obese; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Glucagon; Receptors, Leptin; Succinimides; Trypsin; Venoms

2009